bridion174-sugammadex(專業(yè)版)
【正文】 18:99. ? Serious adverse effects were reported for 2 subjects in the sugammadex group and 3 in the neostigmine group ? Adverse effects were not attributed to the study drug Blobner M, et al. Eur J Anaesthesiol. 2020。 Sugammadex Clinical Application ? Indications: ? Used for adults undergoing surgery for the reversal of neuromuscular blockade (NMB) induced by rocuronium or vecuronium ? Not indicated to reverse blockade of nonsteroidal neuromuscular blocking agents (eg, succinylcholine) ? Not indicated for use in ICU setting Bridion174。 [package insert]. Bridion174。 Sugammadex References 1. 2. Bridion? package insert. Merck. Dec. 2020. 3. Blobner M, Eriksson L, Scholz J, Hillebrand H, Pompei L. Sugammadex ( mg/kg) significantly faster reverses shallow rocuroniuminduced neuromuscular blockade pared with neostigmine (50 181。 [package insert]. Bridion174。Bridion174。 Sugammadex Adverse Effects ? Side effects are dosedependent ? Common (24 mg/kg) {16 mg/kg} [placebo]: ? Nausea (23%) {26%} [23%] ? Vomiting (11%) {15%} [10%] ? Serious (24 mg/kg) {16 mg/kg} [placebo]: ? Prolonged QT interval (1%) {6%
教學(xué)課件相關(guān)推薦
鄂ICP備17016276號(hào)-1